Cargando…
Vancomycin resistance among methicillin resistant Staphylococcus aureus isolates from intensive care units of tertiary care hospitals in Hyderabad
BACKGROUND & OBJECTIVES: Multidrug resistant methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of nosocomial and community acquired infections and is on the rise. The glycopeptide vancomycin has been proposed as the drug of choice for treating such infections. The present study...
Autores principales: | Thati, Venubabu, Shivannavar, Channappa T., Gaddad, Subhaschandra M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249970/ https://www.ncbi.nlm.nih.gov/pubmed/22199111 http://dx.doi.org/10.4103/0971-5916.91001 |
Ejemplares similares
-
Methicillin-resistant Staphylococcus aureus in Neonatal Intensive Care Unit
por: Regev-Yochay, Gili, et al.
Publicado: (2005) -
Incidence of Vancomycin Resistant Phenotype of the Methicillin Resistant Staphylococcus aureus Isolated from a Tertiary Care Hospital in Lahore
por: Saeed, Aqib, et al.
Publicado: (2019) -
Vancomycin Heteroresistance in Methicillin-resistant Staphylococcus aureus, Taiwan
por: Wang, Jiun-Ling, et al.
Publicado: (2004) -
Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil
por: Panesso, Diana, et al.
Publicado: (2015) -
Authors’ response
por: Thati, V., et al.
Publicado: (2012)